메뉴 건너뛰기




Volumn 27, Issue 3, 2012, Pages 354-359

Prediction of human plasma concentration-time profiles of monoclonal antibodies from monkey data by a species-invariant time method

Author keywords

Monoclonal antibody; Species invariant time method

Indexed keywords

MONOCLONAL ANTIBODY;

EID: 84863221758     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-SH-059     Document Type: Article
Times cited : (32)

References (19)
  • 2
    • 71449090902 scopus 로고    scopus 로고
    • Interspecies scaling of therapeutic monoclonal antibodies: Initial look
    • Ling, J., Zhou, H., Jiao, Q. and Davis, H. M.: Interspecies scaling of therapeutic monoclonal antibodies: initial look. J. Clin. Pharmacol., 49: 1382-1402(2009).
    • (2009) J. Clin. Pharmacol , vol.49 , pp. 1382-1402
    • Ling, J.1    Zhou, H.2    Jiao, Q.3    Davis, H.M.4
  • 3
    • 78651400009 scopus 로고    scopus 로고
    • Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: What have we learned?
    • Deng, R., Iyer, S., Theil, F. P., Mortensen, D. L., Fielder, P. J. and Prabhu, S.: Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: What have we learned? MAbs., 3: 61-66 (2011).
    • (2011) MAbs , vol.3 , pp. 61-66
    • Deng, R.1    Iyer, S.2    Theil, F.P.3    Mortensen, D.L.4    Fielder, P.J.5    Prabhu, S.6
  • 5
    • 0021010984 scopus 로고
    • Interspecies pharmacokinetic scaling and the Dedrick plots
    • Boxenbaum, H. and Ronfeld, R.: Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol., 245: R768-R775 (1983).
    • (1983) Am. J. Physiol , vol.245
    • Boxenbaum, H.1    Ronfeld, R.2
  • 6
    • 0021703938 scopus 로고
    • Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm
    • Boxenbaum, H.: Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab. Rev., 15: 1071-1121 (1984).
    • (1984) Drug Metab. Rev , vol.15 , pp. 1071-1121
    • Boxenbaum, H.1
  • 7
    • 84872830556 scopus 로고    scopus 로고
    • Adalimumab (Humira) New Drug Application [NDA]. Available at the website of PMDA (Pharmaceuticals and Medical Devices Agency)
    • Adalimumab (Humira) New Drug Application [NDA]. Available at the website of PMDA (Pharmaceuticals and Medical Devices Agency): http://www.info.pmda.go.jp/shinyaku/P200800019/index.html.
  • 8
    • 33646827589 scopus 로고    scopus 로고
    • Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: Pharmacokinetic, pharmacodynamic, and toxicologic effects
    • Halpern, W. G., Lappin, P., Zanardi, T., Cai, W., Corcoran, M., Zhong, J. and Baker, K. P.: Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Toxicol. Sci., 91: 586-599 (2006).
    • (2006) Toxicol. Sci , vol.91 , pp. 586-599
    • Halpern, W.G.1    Lappin, P.2    Zanardi, T.3    Cai, W.4    Corcoran, M.5    Zhong, J.6    Baker, K.P.7
  • 10
    • 85031181113 scopus 로고    scopus 로고
    • Bevacizumab (Avastin) NDA: Available at the website of PMDA
    • Bevacizumab (Avastin) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200700027/index.html.
  • 11
    • 85031181104 scopus 로고    scopus 로고
    • Etanercept (Enbrel) NDA: Available at the website of PMDA
    • Etanercept (Enbrel) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200500002/index.html.
  • 12
    • 85031189519 scopus 로고    scopus 로고
    • Infliximab (Remicade) NDA: Available at the website of PMDA
    • Infliximab (Remicade) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200300015/index.html.
  • 13
    • 85031191290 scopus 로고    scopus 로고
    • Omalizumab (Xolair) NDA: Available at the website of PMDA
    • Omalizumab (Xolair) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200900001/index.html.
  • 14
    • 85031190273 scopus 로고    scopus 로고
    • Basiliximab (Simulect) NDA: Available at the website of PMDA
    • Basiliximab (Simulect) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200200005/index.html.
  • 15
    • 85031186207 scopus 로고    scopus 로고
    • Cetuximab (Erbitux) NDA: Available at the website of PMDA
    • Cetuximab (Erbitux) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200800039/index.html.
  • 16
    • 85031182099 scopus 로고    scopus 로고
    • Palivizumab (Synagis) NDA: Available at the website of PMDA
    • Palivizumab (Synagis) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200200010/index.html.
  • 17
    • 85031191579 scopus 로고    scopus 로고
    • Rituximab (Rituxan) NDA: Available at the website of PMDA
    • Rituximab (Rituxan) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200100018/index.html.
  • 18
    • 85031180321 scopus 로고    scopus 로고
    • Tocilizumab (Actemra) NDA: Available at the website of PMDA
    • Tocilizumab (Actemra) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200500016/index.html.
  • 19
    • 85031182568 scopus 로고    scopus 로고
    • Trastuzumab (Herceptin) NDA: Available at the website of PMDA
    • Trastuzumab (Herceptin) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200100003/index.html.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.